Cardioprotective effects of nicorandil in rabbits anaesthetized with halothane: Potentiation of ischaemic preconditioning via K(ATP) channels

Clinical and Experimental Pharmacology and Physiology

Volumn 27, Issue 10, 2000, Pages 810-817

  Nakae, Ichiro ^a   Takaoka, Atsushi ^a   Mitsunami, Kenichi ^a   Yabe, Takahiro ^a   Ito, Makoto ^a   Takahashi, Masayuki ^a   Matsumoto, Tetsuya ^a   Omura, Tomoko ^a   Yokohama, Hiroshi ^a   Kinoshita, Masahiko ^a  

^a SHIGA UNIVERSITY OF MEDICAL SCIENCE   (Japan)

Author keywords

ATP sensitive K+ (K(ATP)) channel; Ischaemic preconditioning; Myocardial infarction; Nicorandil; Rabbit

Indexed keywords

GLIBENCLAMIDE; HALOTHANE; KETAMINE; NICORANDIL; PENTOBARBITAL; PINACIDIL; POTASSIUM CHANNEL; XYLAZINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BODY WEIGHT; CONTROLLED STUDY; DRUG EFFECT; DRUG MECHANISM; HEART INFARCTION PREVENTION; HEART INFARCTION SIZE; HEART MUSCLE REPERFUSION; HEART PROTECTION; HEART RATE; HEART WEIGHT; MALE; MEAN ARTERIAL PRESSURE; NONHUMAN; RABBIT; RISK;

ANESTHESIA, INHALATION; ANESTHETICS, INHALATION; ANIMALS; ANTI-ARRHYTHMIA AGENTS; ATP-BINDING CASSETTE TRANSPORTERS; BODY WEIGHT; DECANOIC ACIDS; HALOTHANE; HEART; HEART RATE; HEMODYNAMIC PROCESSES; HYDROXY ACIDS; ISCHEMIC PRECONDITIONING, MYOCARDIAL; MAGNETIC RESONANCE SPECTROSCOPY; MALE; MYOCARDIAL INFARCTION; NICORANDIL; POTASSIUM CHANNELS; POTASSIUM CHANNELS, INWARDLY RECTIFYING; RABBITS; VASODILATOR AGENTS;

EID: 0033798207     PISSN: 03051870     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1440-1681.2000.03347.x     Document Type: Article

References (47)

1. Preconditioning with ischemia: A delay of lethal cell injury in ischemic myocardium
2. Infarct size limitation by preconditioning: Its phenomenological features and the key role of adenosine
3. Preconditioning the human myocardium: Recent advances and aspirations for the development of a new means of cardioprotection in clinical practice
4. Blockade of ATP-sensitive potassium channels prevents myocardial preconditioning in dogs
5. Role of myocardial ATP-sensitive potassium channels in mediating preconditioning in the dog heart and their possible interaction with adenosine A1-receptors
6. The protective effects of cromakalim and pinacidil on reperfusion function and infarct size in isolated perfused rat hearts and anesthetized dogs
7. Blockade of ATP-sensitive potassium channels increases infarct size but does not prevent preconditioning in rabbit hearts
8. Limitation of infarct size in the rabbit by ischaemic preconditioning is reversible with glibenclamide
9. Ketamine-xylazine anaesthesia permits a K(ATP) channel antagonist to attenuate preconditioning in rabbit myocardium
10. Glibenclamide, a blocker of ATP-sensitive potassium channels, abolishes infarct size limitation by preconditioning in rabbits anesthetized with xylazine/pentobarbital but not with pentobarbital alone
11. Pharmacology and therapeutic effects of nicorandil
12. Nicorandil as a hybrid between nitrates and potassium channel activators
13. Comparative efficacy of high-dose versus low-dose nicorandil therapy for chronic stable angina pectoris
14. Effects of nicorandil on exercise tolerance in patients with stable effort angina: A double-blind study
15. Comparative efficacy of nicorandil and nitroglycerin in patients with chronic stable angina pectoris
16. Dipyridamole potentiates the myocardial infarct size-limiting effect of ischemic preconditioning
17. Specific block of the anti-ischemic actions of cromakalim by sodium 5-hydroxydecanoate
18. + channel by 5-hydroxydecanoate in guinea pig ventricular myocytes
19. Triphenyltetrazolium staining of irreversible ischemic injury following coronary artery occlusion in rats
20. Renal ischemia/reperfusion remotely improves myocardial energy metabolism during myocardial ischemia via adenosine receptors in rabbits: Effects of 'remote preconditioning'
21. Mechanism of the vasodilatory action of nicorandil on coronary circulation in dogs
22. Cardioprotective effects of nicorandil
23. Effects of nicorandil and glyceryl trinitrate on infarct size, adenosine release, and neutrophile infiltration in the dog
24. Infarct size-reducing effect of nicorandil is mediated by the K(ATP) channel but not by its nitrate-like properties in dogs
25. Effects of nicorandil, a new antianginal agent, and nifedipine on collateral blood flow in a chronic coronary occlusion model
26. Species variation in the coronary collateral circulation during regional myocardial ischaemia: A critical determinant of the rate of evolution and extent of myocardial infarction
27. Progression of myocardial infarction in a collateral flow deficient species
28. K(ATP) channels contribute to the cardioprotection of preconditioning independent of anaesthetics in rabbit hearts
29. Coronary effects of nicorandil in comparison with nitroglycerin in chronic conscious dogs
30. Nicorandil reduces myocardial infarct size by opening the K(ATP) channel in rabbits
31. Myocardial protection afforded by nicorandil and ischaemic preconditioning in a rabbit infarct model in vivo
32. Infarct-size limitation by preconditioning is enhanced by dipyridamole administered before but not after preconditioning: Evidence for the role of interstitial adenosine level during preconditioning as a primary determinant of cardioprotection
33. Preconditioning with 15 minute ischemia extends myocardial infarct size after subsequent 30 minute ischemia in rabbits
34. Role of adenosine receptor activation in myocardial infarct size limitation by ischaemic preconditioning
35. Ischaemic preconditioning may abolish the protection afforded by ATP-sensitive potassium channel openers in isolated human atrial muscle
36. Preconditioning improves energy metabolism during reperfusion but does not attenuate myocardial stunning in porcine hearts
37. Ischemic preconditioning preserves creatine phosphate and intracellular pH
38. Volatile anesthetics protect the ischemic rabbit myocardium from infarction
39. Isoflurane mimics ischemic preconditioning via activation of K(ATP) channels
40. Activation of ATP-sensitive potassium channels lowers threshold for ischemic preconditioning in dogs
41. Effects of the K(ATP) channel opener bimakalim on coronary blood flow, monophasic action potential duration, and infarct size in dogs
42. Cardioprotection with the K(ATP) opener cromakalim is not correlated with ischemic myocardial action potential duration
43. Shortening of action potential duration is not a prerequisite for cardiac protection by ischemic preconditioning or a K(ATP) channel opener
44. Mitochondrial ATP-dependent potassium channels. Novel effectors of cardioprotection?
45. Nicorandil, a potent cardioprotective agent, acts by opening mitochondrial ATP-dependent potassium channels
46. Beneficial effects of concomitant administration of isoflurane and nicorandil
47. Potassium channels and preconditioning of isolated rabbit cardiomyocytes: Effects of glyburide and pinacidil